Table of Content

1 Nasal Decongestant Market Overview
1.1 Product Overview and Scope of Nasal Decongestant
1.2 Nasal Decongestant Segment by Type
1.2.1 Global Nasal Decongestant Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Nasal Strips
1.2.3 Tablet
1.2.4 Spray
1.2.5 Capsule
1.3 Nasal Decongestant Segment by Application
1.3.1 Nasal Decongestant Sales Comparison by Application: (2021-2027)
1.3.2 Asthma
1.3.3 Cold
1.3.4 Nasal Allergies
1.4 Global Nasal Decongestant Market Size Estimates and Forecasts
1.4.1 Global Nasal Decongestant Revenue 2016-2027
1.4.2 Global Nasal Decongestant Sales 2016-2027
1.4.3 Nasal Decongestant Market Size by Region: 2016 Versus 2021 Versus 2027

2 Nasal Decongestant Market Competition by Manufacturers
2.1 Global Nasal Decongestant Sales Market Share by Manufacturers (2016-2021)
2.2 Global Nasal Decongestant Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Nasal Decongestant Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Nasal Decongestant Manufacturing Sites, Area Served, Product Type
2.5 Nasal Decongestant Market Competitive Situation and Trends
2.5.1 Nasal Decongestant Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Nasal Decongestant Players Market Share by Revenue
2.5.3 Global Nasal Decongestant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Nasal Decongestant Retrospective Market Scenario by Region
3.1 Global Nasal Decongestant Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Nasal Decongestant Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Nasal Decongestant Market Facts & Figures by Country
3.3.1 North America Nasal Decongestant Sales by Country
3.3.2 North America Nasal Decongestant Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Nasal Decongestant Market Facts & Figures by Country
3.4.1 Europe Nasal Decongestant Sales by Country
3.4.2 Europe Nasal Decongestant Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Nasal Decongestant Market Facts & Figures by Region
3.5.1 Asia Pacific Nasal Decongestant Sales by Region
3.5.2 Asia Pacific Nasal Decongestant Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Nasal Decongestant Market Facts & Figures by Country
3.6.1 Latin America Nasal Decongestant Sales by Country
3.6.2 Latin America Nasal Decongestant Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Nasal Decongestant Market Facts & Figures by Country
3.7.1 Middle East and Africa Nasal Decongestant Sales by Country
3.7.2 Middle East and Africa Nasal Decongestant Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Nasal Decongestant Historic Market Analysis by Type
4.1 Global Nasal Decongestant Sales Market Share by Type (2016-2021)
4.2 Global Nasal Decongestant Revenue Market Share by Type (2016-2021)
4.3 Global Nasal Decongestant Price by Type (2016-2021)

5 Global Nasal Decongestant Historic Market Analysis by Application
5.1 Global Nasal Decongestant Sales Market Share by Application (2016-2021)
5.2 Global Nasal Decongestant Revenue Market Share by Application (2016-2021)
5.3 Global Nasal Decongestant Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Nasal Decongestant Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Abbott Laboratories Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Glaxosmithkline
6.2.1 Glaxosmithkline Corporation Information
6.2.2 Glaxosmithkline Description and Business Overview
6.2.3 Glaxosmithkline Nasal Decongestant Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Glaxosmithkline Product Portfolio
6.2.5 Glaxosmithkline Recent Developments/Updates
6.3 Cipla
6.3.1 Cipla Corporation Information
6.3.2 Cipla Description and Business Overview
6.3.3 Cipla Nasal Decongestant Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Cipla Product Portfolio
6.3.5 Cipla Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Nasal Decongestant Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bayer Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 ADAPT Pharma
6.5.1 ADAPT Pharma Corporation Information
6.5.2 ADAPT Pharma Description and Business Overview
6.5.3 ADAPT Pharma Nasal Decongestant Sales, Revenue and Gross Margin (2016-2021)
6.5.4 ADAPT Pharma Product Portfolio
6.5.5 ADAPT Pharma Recent Developments/Updates
6.6 Patrick Parsons
6.6.1 Patrick Parsons Corporation Information
6.6.2 Patrick Parsons Description and Business Overview
6.6.3 Patrick Parsons Nasal Decongestant Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Patrick Parsons Product Portfolio
6.6.5 Patrick Parsons Recent Developments/Updates
6.7 Nidda Healthcare
6.6.1 Nidda Healthcare Corporation Information
6.6.2 Nidda Healthcare Description and Business Overview
6.6.3 Nidda Healthcare Nasal Decongestant Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Nidda Healthcare Product Portfolio
6.7.5 Nidda Healthcare Recent Developments/Updates
6.8 Procter and Gamble
6.8.1 Procter and Gamble Corporation Information
6.8.2 Procter and Gamble Description and Business Overview
6.8.3 Procter and Gamble Nasal Decongestant Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Procter and Gamble Product Portfolio
6.8.5 Procter and Gamble Recent Developments/Updates
6.9 Rugby Laboratories
6.9.1 Rugby Laboratories Corporation Information
6.9.2 Rugby Laboratories Description and Business Overview
6.9.3 Rugby Laboratories Nasal Decongestant Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Rugby Laboratories Product Portfolio
6.9.5 Rugby Laboratories Recent Developments/Updates

7 Nasal Decongestant Manufacturing Cost Analysis
7.1 Nasal Decongestant Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Nasal Decongestant
7.4 Nasal Decongestant Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Nasal Decongestant Distributors List
8.3 Nasal Decongestant Customers

9 Nasal Decongestant Market Dynamics
9.1 Nasal Decongestant Industry Trends
9.2 Nasal Decongestant Growth Drivers
9.3 Nasal Decongestant Market Challenges
9.4 Nasal Decongestant Market Restraints

10 Global Market Forecast
10.1 Nasal Decongestant Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Nasal Decongestant by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Nasal Decongestant by Type (2022-2027)
10.2 Nasal Decongestant Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Nasal Decongestant by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Nasal Decongestant by Application (2022-2027)
10.3 Nasal Decongestant Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Nasal Decongestant by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Nasal Decongestant by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Nasal Decongestant Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Nasal Decongestant Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Nasal Decongestant Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Nasal Decongestant Covered in This Study
Table 5. Global Nasal Decongestant Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Nasal Decongestant Sales Share by Manufacturers (2016-2021)
Table 7. Global Nasal Decongestant Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Nasal Decongestant Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Nasal Decongestant Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Nasal Decongestant Manufacturing Sites and Area Served
Table 11. Manufacturers Nasal Decongestant Product Type
Table 12. Global Nasal Decongestant Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Nasal Decongestant by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasal Decongestant as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Nasal Decongestant Sales by Region (2016-2021) & (K Units)
Table 16. Global Nasal Decongestant Sales Market Share by Region (2016-2021)
Table 17. Global Nasal Decongestant Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Nasal Decongestant Sales by Country (2016-2021) & (K Units)
Table 19. North America Nasal Decongestant Sales Market Share by Country (2016-2021)
Table 20. North America Nasal Decongestant Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Nasal Decongestant Revenue Market Share by Country (2016-2021)
Table 22. Europe Nasal Decongestant Sales by Country (2016-2021) & (K Units)
Table 23. Europe Nasal Decongestant Sales Market Share by Country (2016-2021)
Table 24. Europe Nasal Decongestant Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Nasal Decongestant Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Nasal Decongestant Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Nasal Decongestant Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Nasal Decongestant Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Nasal Decongestant Revenue Market Share by Region (2016-2021)
Table 30. Latin America Nasal Decongestant Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Nasal Decongestant Sales Market Share by Country (2016-2021)
Table 32. Latin America Nasal Decongestant Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Nasal Decongestant Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Nasal Decongestant Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Nasal Decongestant Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Nasal Decongestant Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Nasal Decongestant Revenue Market Share by Country (2016-2021)
Table 38. Global Nasal Decongestant Sales (K Units) by Type (2016-2021)
Table 39. Global Nasal Decongestant Sales Market Share by Type (2016-2021)
Table 40. Global Nasal Decongestant Revenue (Million US$) by Type (2016-2021)
Table 41. Global Nasal Decongestant Revenue Share by Type (2016-2021)
Table 42. Global Nasal Decongestant Price (US$/Unit) by Type (2016-2021)
Table 43. Global Nasal Decongestant Sales (K Units) by Application (2016-2021)
Table 44. Global Nasal Decongestant Sales Market Share by Application (2016-2021)
Table 45. Global Nasal Decongestant Revenue (Million US$) by Application (2016-2021)
Table 46. Global Nasal Decongestant Revenue Share by Application (2016-2021)
Table 47. Global Nasal Decongestant Price (US$/Unit) by Application (2016-2021)
Table 48. Abbott Laboratories Corporation Information
Table 49. Abbott Laboratories Description and Business Overview
Table 50. Abbott Laboratories Nasal Decongestant Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Abbott Laboratories Nasal Decongestant Product
Table 52. Abbott Laboratories Recent Developments/Updates
Table 53. Glaxosmithkline Corporation Information
Table 54. Glaxosmithkline Description and Business Overview
Table 55. Glaxosmithkline Nasal Decongestant Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Glaxosmithkline Nasal Decongestant Product
Table 57. Glaxosmithkline Recent Developments/Updates
Table 58. Cipla Corporation Information
Table 59. Cipla Description and Business Overview
Table 60. Cipla Nasal Decongestant Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Cipla Nasal Decongestant Product
Table 62. Cipla Recent Developments/Updates
Table 63. Bayer Corporation Information
Table 64. Bayer Description and Business Overview
Table 65. Bayer Nasal Decongestant Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Bayer Nasal Decongestant Product
Table 67. Bayer Recent Developments/Updates
Table 68. ADAPT Pharma Corporation Information
Table 69. ADAPT Pharma Description and Business Overview
Table 70. ADAPT Pharma Nasal Decongestant Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. ADAPT Pharma Nasal Decongestant Product
Table 72. ADAPT Pharma Recent Developments/Updates
Table 73. Patrick Parsons Corporation Information
Table 74. Patrick Parsons Description and Business Overview
Table 75. Patrick Parsons Nasal Decongestant Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Patrick Parsons Nasal Decongestant Product
Table 77. Patrick Parsons Recent Developments/Updates
Table 78. Nidda Healthcare Corporation Information
Table 79. Nidda Healthcare Description and Business Overview
Table 80. Nidda Healthcare Nasal Decongestant Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Nidda Healthcare Nasal Decongestant Product
Table 82. Nidda Healthcare Recent Developments/Updates
Table 83. Procter and Gamble Corporation Information
Table 84. Procter and Gamble Description and Business Overview
Table 85. Procter and Gamble Nasal Decongestant Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Procter and Gamble Nasal Decongestant Product
Table 87. Procter and Gamble Recent Developments/Updates
Table 88. Rugby Laboratories Corporation Information
Table 89. Rugby Laboratories Description and Business Overview
Table 90. Rugby Laboratories Nasal Decongestant Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Rugby Laboratories Nasal Decongestant Product
Table 92. Rugby Laboratories Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Nasal Decongestant Distributors List
Table 96. Nasal Decongestant Customers List
Table 97. Nasal Decongestant Market Trends
Table 98. Nasal Decongestant Growth Drivers
Table 99. Nasal Decongestant Market Restraints
Table 100. Global Nasal Decongestant Sales Forecast by Type (2022-2027) & (K Units)
Table 101. Global Nasal Decongestant Sales Market Share Forecast by Type (2022-2027)
Table 102. Global Nasal Decongestant Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 103. Global Nasal Decongestant Revenue Market Share Forecast by Type (2022-2027)
Table 104. Global Nasal Decongestant Sales Forecast by Application (2022-2027) & (K Units)
Table 105. Global Nasal Decongestant Sales Market Share Forecast by Application (2022-2027)
Table 106. Global Nasal Decongestant Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 107. Global Nasal Decongestant Revenue Market Share Forecast by Application (2022-2027)
Table 108. Global Nasal Decongestant Sales Forecast by Region (2022-2027) & (K Units)
Table 109. Global Nasal Decongestant Sales Market Share Forecast by Region (2022-2027)
Table 110. Global Nasal Decongestant Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 111. Global Nasal Decongestant Revenue Market Share Forecast by Region (2022-2027)
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nasal Decongestant
Figure 2. Global Nasal Decongestant Market Share by Type in 2020 & 2027
Figure 3. Nasal Strips Product Picture
Figure 4. Tablet Product Picture
Figure 5. Spray Product Picture
Figure 6. Capsule Product Picture
Figure 7. Global Nasal Decongestant Market Share by Application in 2020 & 2027
Figure 8. Asthma
Figure 9. Cold
Figure 10. Nasal Allergies
Figure 11. Global Nasal Decongestant Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Nasal Decongestant Market Size 2016-2027 (US$ Million)
Figure 13. Global Nasal Decongestant Sales 2016-2027 (K Units)
Figure 14. Global Nasal Decongestant Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Nasal Decongestant Sales Share by Manufacturers in 2020
Figure 16. Global Nasal Decongestant Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Nasal Decongestant Players: Market Share by Revenue in 2020
Figure 18. Nasal Decongestant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Nasal Decongestant Sales Market Share by Region (2016-2021)
Figure 20. Global Nasal Decongestant Sales Market Share by Region in 2020
Figure 21. Global Nasal Decongestant Revenue Market Share by Region (2016-2021)
Figure 22. Global Nasal Decongestant Revenue Market Share by Region in 2020
Figure 23. U.S. Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Nasal Decongestant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Nasal Decongestant by Type (2016-2021)
Figure 48. Sales Market Share of Nasal Decongestant by Application (2016-2021)
Figure 49. Sales Market Share of Nasal Decongestant by Application in 2020
Figure 50. Revenue Share of Nasal Decongestant by Application (2016-2021)
Figure 51. Revenue Share of Nasal Decongestant by Application in 2020
Figure 52. Manufacturing Cost Structure of Nasal Decongestant
Figure 53. Manufacturing Process Analysis of Nasal Decongestant
Figure 54. Nasal Decongestant Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed